Role of biomarkers in the diagnosis of invasive aspergillosis in immunocompromised patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-0711
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Role of biomarkers in the diagnosis of invasive aspergillosis in immunocompromised patients ; volume:21 ; number:1 ; day:1 ; month:11 ; year:2022 ; pages:1-8 ; date:12.2022
Annals of clinical microbiology and antimicrobials ; 21, Heft 1 (1.11.2022), 1-8, 12.2022
- Creator
-
Badiee, Parisa
Ghasemi, Fatemeh
Jafarian, Hadis
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12941-022-00539-x
- URN
-
urn:nbn:de:101:1-2023011621123311218231
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Badiee, Parisa
- Ghasemi, Fatemeh
- Jafarian, Hadis
- SpringerLink (Online service)
Other Objects (12)
Aspergillus-PCR in bronchoalveolar lavage for detection of invasive pulmonary aspergillosis in immunocompromised patients
Serum galactomannan index for early prediction of mortality in immunocompromised children with invasive pulmonary aspergillosis
Triacetylfusarinine C: A urine biomarker for diagnosis of invasive aspergillosis
Immunocompromised hosts: Infections and biomarkers
Lateral Flow Assays for the Diagnosis of Invasive Aspergillosis: Current Status
Usefulness of molecular biology performed with formaldehyde-fixed paraffin embedded tissue for the diagnosis of combined pulmonary invasive mucormycosis and aspergillosis in an immunocompromised patient
COVID-19-associated invasive pulmonary aspergillosis
CD8+T-cell counts: an early predictor of risk and mortality in critically ill immunocompromised patients with invasive pulmonary aspergillosis
New clinical algorithm including fungal biomarkers to better diagnose probable invasive pulmonary aspergillosis in ICU
Invasive aspergillosis in solid organ transplant patients: diagnosis, prophylaxis, treatment, and assessment of response
Metagenomic next-generation sequencing and galactomannan testing for the diagnosis of invasive pulmonary aspergillosis
Strongyloidiasis co-occurrence with tuberculosis and aspergillosis in immunocompromised patients: a global scoping review
Aspergillus-PCR in bronchoalveolar lavage for detection of invasive pulmonary aspergillosis in immunocompromised patients
Serum galactomannan index for early prediction of mortality in immunocompromised children with invasive pulmonary aspergillosis
Triacetylfusarinine C: A urine biomarker for diagnosis of invasive aspergillosis
Immunocompromised hosts: Infections and biomarkers
Lateral Flow Assays for the Diagnosis of Invasive Aspergillosis: Current Status
Usefulness of molecular biology performed with formaldehyde-fixed paraffin embedded tissue for the diagnosis of combined pulmonary invasive mucormycosis and aspergillosis in an immunocompromised patient
COVID-19-associated invasive pulmonary aspergillosis
CD8+T-cell counts: an early predictor of risk and mortality in critically ill immunocompromised patients with invasive pulmonary aspergillosis
New clinical algorithm including fungal biomarkers to better diagnose probable invasive pulmonary aspergillosis in ICU
Invasive aspergillosis in solid organ transplant patients: diagnosis, prophylaxis, treatment, and assessment of response
Metagenomic next-generation sequencing and galactomannan testing for the diagnosis of invasive pulmonary aspergillosis
Strongyloidiasis co-occurrence with tuberculosis and aspergillosis in immunocompromised patients: a global scoping review
Aspergillus-PCR in bronchoalveolar lavage for detection of invasive pulmonary aspergillosis in immunocompromised patients
Serum galactomannan index for early prediction of mortality in immunocompromised children with invasive pulmonary aspergillosis
Triacetylfusarinine C: A urine biomarker for diagnosis of invasive aspergillosis
Immunocompromised hosts: Infections and biomarkers
Lateral Flow Assays for the Diagnosis of Invasive Aspergillosis: Current Status
Usefulness of molecular biology performed with formaldehyde-fixed paraffin embedded tissue for the diagnosis of combined pulmonary invasive mucormycosis and aspergillosis in an immunocompromised patient
COVID-19-associated invasive pulmonary aspergillosis
CD8+T-cell counts: an early predictor of risk and mortality in critically ill immunocompromised patients with invasive pulmonary aspergillosis
New clinical algorithm including fungal biomarkers to better diagnose probable invasive pulmonary aspergillosis in ICU
Invasive aspergillosis in solid organ transplant patients: diagnosis, prophylaxis, treatment, and assessment of response
Metagenomic next-generation sequencing and galactomannan testing for the diagnosis of invasive pulmonary aspergillosis